Psilocybin-Based Drug Candidate Gains Patent
Ahead of the competition, drug developers are locking in patents while the psychedelic renaissance takes the medical community by storm. Enveric Biosciences, a biotechnology company focusing on the development of novel drugs primarily for the treatment of depression, anxiety, and addiction disorders, announced in a Sept. 20 press release that the United States Patent and […]